Global Covid-19 Therapeutic Market 2021 by Company, Regions, Type and Application, Forecast to 2026

March 2021 | 124 pages | ID: GC952DBEE697EN
GlobalInfoResearch

Abstracts

The Covid-19 Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Covid-19 Therapeutic size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Covid-19 Therapeutic market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Covid-19 Therapeutic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Immunotherapy
• Life Support
• Antiviral Medicine
• Plasma Therapy
• Others

Market segment by Application, can be divided into

• Children
• Adult

Market segment by players, this report covers

• Cadila Healthcare
• Johnson & Johnson
• ImmunoPrecise
• Novartis
• AstraZeneca
• Cipla
• AbbVie
• Bayer
• Regeneron Pharmaceuticals
• Ascletis Pharma
• GlaxoSmithKline
• Gilead Sciences
• Pharmstandard
• Fujifilm Holdings
• Zhejiang Hisun Pharmaceutical Co. Ltd
• Roche
• Sanofi
• Pfizer

Market segment by regions, regional analysis covers

• North America (United States, Canada, and Mexico)
• Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
• South America (Brazil, Argentina, Rest of South America)
• Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Covid-19 Therapeutic
1.2 Classification of Covid-19 Therapeutic by Type
  1.2.1 Overview: Global Covid-19 Therapeutic Market Size by Type: 2020 Versus 2021 Versus 2026
  1.2.2 Global Covid-19 Therapeutic Revenue Market Share by Type in 2020
  1.2.3 Immunotherapy
  1.2.4 Life Support
  1.2.5 Antiviral Medicine
  1.2.6 Plasma Therapy
  1.2.7 Others
1.3 Global Covid-19 Therapeutic Market by Application
  1.3.1 Overview: Global Covid-19 Therapeutic Market Size by Application: 2020 Versus 2021 Versus 2026
  1.3.2 Children
  1.3.3 Adult
1.4 Global Covid-19 Therapeutic Market Size & Forecast
1.5 Global Covid-19 Therapeutic Market Size and Forecast by Region
  1.5.1 Global Covid-19 Therapeutic Market Size by Region: 2016 VS 2021 VS 2026
  1.5.2 Global Covid-19 Therapeutic Market Size by Region, (2016-2021)
  1.5.3 North America Covid-19 Therapeutic Market Size and Prospect (2016-2026)
  1.5.4 Europe Covid-19 Therapeutic Market Size and Prospect (2016-2026)
  1.5.5 Asia-Pacific Covid-19 Therapeutic Market Size and Prospect (2016-2026)
  1.5.6 South America Covid-19 Therapeutic Market Size and Prospect (2016-2026)
  1.5.7 Middle East and Africa Covid-19 Therapeutic Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
  1.6.1 Covid-19 Therapeutic Market Drivers
  1.6.2 Covid-19 Therapeutic Market Restraints
  1.6.3 Covid-19 Therapeutic Trends Analysis

2 COMPANY PROFILES

2.1 Cadila Healthcare
  2.1.1 Cadila Healthcare Details
  2.1.2 Cadila Healthcare Major Business
  2.1.3 Cadila Healthcare Covid-19 Therapeutic Product and Solutions
  2.1.4 Cadila Healthcare Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.1.5 Cadila Healthcare Recent Developments and Future Plans
2.2 Johnson & Johnson
  2.2.1 Johnson & Johnson Details
  2.2.2 Johnson & Johnson Major Business
  2.2.3 Johnson & Johnson Covid-19 Therapeutic Product and Solutions
  2.2.4 Johnson & Johnson Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 ImmunoPrecise
  2.3.1 ImmunoPrecise Details
  2.3.2 ImmunoPrecise Major Business
  2.3.3 ImmunoPrecise Covid-19 Therapeutic Product and Solutions
  2.3.4 ImmunoPrecise Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.3.5 ImmunoPrecise Recent Developments and Future Plans
2.4 Novartis
  2.4.1 Novartis Details
  2.4.2 Novartis Major Business
  2.4.3 Novartis Covid-19 Therapeutic Product and Solutions
  2.4.4 Novartis Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.4.5 Novartis Recent Developments and Future Plans
2.5 AstraZeneca
  2.5.1 AstraZeneca Details
  2.5.2 AstraZeneca Major Business
  2.5.3 AstraZeneca Covid-19 Therapeutic Product and Solutions
  2.5.4 AstraZeneca Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.5.5 AstraZeneca Recent Developments and Future Plans
2.6 Cipla
  2.6.1 Cipla Details
  2.6.2 Cipla Major Business
  2.6.3 Cipla Covid-19 Therapeutic Product and Solutions
  2.6.4 Cipla Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.6.5 Cipla Recent Developments and Future Plans
2.7 AbbVie
  2.7.1 AbbVie Details
  2.7.2 AbbVie Major Business
  2.7.3 AbbVie Covid-19 Therapeutic Product and Solutions
  2.7.4 AbbVie Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.7.5 AbbVie Recent Developments and Future Plans
2.8 Bayer
  2.8.1 Bayer Details
  2.8.2 Bayer Major Business
  2.8.3 Bayer Covid-19 Therapeutic Product and Solutions
  2.8.4 Bayer Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.8.5 Bayer Recent Developments and Future Plans
2.9 Regeneron Pharmaceuticals
  2.9.1 Regeneron Pharmaceuticals Details
  2.9.2 Regeneron Pharmaceuticals Major Business
  2.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Product and Solutions
  2.9.4 Regeneron Pharmaceuticals Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.9.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.10 Ascletis Pharma
  2.10.1 Ascletis Pharma Details
  2.10.2 Ascletis Pharma Major Business
  2.10.3 Ascletis Pharma Covid-19 Therapeutic Product and Solutions
  2.10.4 Ascletis Pharma Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.10.5 Ascletis Pharma Recent Developments and Future Plans
2.11 GlaxoSmithKline
  2.11.1 GlaxoSmithKline Details
  2.11.2 GlaxoSmithKline Major Business
  2.11.3 GlaxoSmithKline Covid-19 Therapeutic Product and Solutions
  2.11.4 GlaxoSmithKline Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.11.5 GlaxoSmithKline Recent Developments and Future Plans
2.12 Gilead Sciences
  2.12.1 Gilead Sciences Details
  2.12.2 Gilead Sciences Major Business
  2.12.3 Gilead Sciences Covid-19 Therapeutic Product and Solutions
  2.12.4 Gilead Sciences Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.12.5 Gilead Sciences Recent Developments and Future Plans
2.13 Pharmstandard
  2.13.1 Pharmstandard Details
  2.13.2 Pharmstandard Major Business
  2.13.3 Pharmstandard Covid-19 Therapeutic Product and Solutions
  2.13.4 Pharmstandard Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.13.5 Pharmstandard Recent Developments and Future Plans
2.14 Fujifilm Holdings
  2.14.1 Fujifilm Holdings Details
  2.14.2 Fujifilm Holdings Major Business
  2.14.3 Fujifilm Holdings Covid-19 Therapeutic Product and Solutions
  2.14.4 Fujifilm Holdings Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.14.5 Fujifilm Holdings Recent Developments and Future Plans
2.15 Zhejiang Hisun Pharmaceutical Co. Ltd
  2.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Details
  2.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
  2.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Product and Solutions
  2.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
2.16 Roche
  2.16.1 Roche Details
  2.16.2 Roche Major Business
  2.16.3 Roche Covid-19 Therapeutic Product and Solutions
  2.16.4 Roche Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.16.5 Roche Recent Developments and Future Plans
2.17 Sanofi
  2.17.1 Sanofi Details
  2.17.2 Sanofi Major Business
  2.17.3 Sanofi Covid-19 Therapeutic Product and Solutions
  2.17.4 Sanofi Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.17.5 Sanofi Recent Developments and Future Plans
2.18 Pfizer
  2.18.1 Pfizer Details
  2.18.2 Pfizer Major Business
  2.18.3 Pfizer Covid-19 Therapeutic Product and Solutions
  2.18.4 Pfizer Covid-19 Therapeutic Revenue, Gross Margin and Market Share (2019-2021)
  2.18.5 Pfizer Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Covid-19 Therapeutic Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
  3.2.1 Top 3 Covid-19 Therapeutic Players Market Share
  3.2.2 Top 10 Covid-19 Therapeutic Players Market Share
  3.2.3 Market Competition Trend
3.3 Covid-19 Therapeutic Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Covid-19 Therapeutic Revenue and Market Share by Type (2016-2021)
4.2 Global Covid-19 Therapeutic Market Forecast by Type (2021-2026)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Covid-19 Therapeutic Revenue Market Share by Application (2016-2021)
5.2 Covid-19 Therapeutic Market Forecast by Application (2021-2026)

6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

6.1 North America Covid-19 Therapeutic Revenue by Type (2016-2026)
6.2 North America Covid-19 Therapeutic Revenue by Application (2016-2026)
6.3 North America Covid-19 Therapeutic Market Size by Country
  6.3.1 North America Covid-19 Therapeutic Revenue by Country (2016-2026)
  6.3.2 United States Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  6.3.3 Canada Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  6.3.4 Mexico Covid-19 Therapeutic Market Size and Forecast (2016-2026)

7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 Europe Covid-19 Therapeutic Revenue by Type (2016-2026)
7.2 Europe Covid-19 Therapeutic Revenue by Application (2016-2026)
7.3 Europe Covid-19 Therapeutic Market Size by Country
  7.3.1 Europe Covid-19 Therapeutic Revenue by Country (2016-2026)
  7.3.2 Germany Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  7.3.3 France Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  7.3.4 United Kingdom Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  7.3.5 Russia Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  7.3.6 Italy Covid-19 Therapeutic Market Size and Forecast (2016-2026)

8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

8.1 Asia-Pacific Covid-19 Therapeutic Revenue by Type (2016-2026)
8.2 Asia-Pacific Covid-19 Therapeutic Revenue by Application (2016-2026)
8.3 Asia-Pacific Covid-19 Therapeutic Market Size by Region
  8.3.1 Asia-Pacific Covid-19 Therapeutic Revenue by Region (2016-2026)
  8.3.2 China Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  8.3.3 Japan Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  8.3.4 South Korea Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  8.3.5 India Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  8.3.6 Southeast Asia Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  8.3.7 Australia Covid-19 Therapeutic Market Size and Forecast (2016-2026)

9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

9.1 South America Covid-19 Therapeutic Revenue by Type (2016-2026)
9.2 South America Covid-19 Therapeutic Revenue by Application (2016-2026)
9.3 South America Covid-19 Therapeutic Market Size by Country
  9.3.1 South America Covid-19 Therapeutic Revenue by Country (2016-2026)
  9.3.2 Brazil Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  9.3.3 Argentina Covid-19 Therapeutic Market Size and Forecast (2016-2026)

10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

10.1 Middle East & Africa Covid-19 Therapeutic Revenue by Type (2016-2026)
10.2 Middle East & Africa Covid-19 Therapeutic Revenue by Application (2016-2026)
10.3 Middle East & Africa Covid-19 Therapeutic Market Size by Country
  10.3.1 Middle East & Africa Covid-19 Therapeutic Revenue by Country (2016-2026)
  10.3.2 Turkey Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  10.3.3 Saudi Arabia Covid-19 Therapeutic Market Size and Forecast (2016-2026)
  10.3.4 UAE Covid-19 Therapeutic Market Size and Forecast (2016-2026)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Covid-19 Therapeutic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Covid-19 Therapeutic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Covid-19 Therapeutic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Covid-19 Therapeutic Revenue (USD Million) by Region (2016-2021)
Table 5. Global Covid-19 Therapeutic Revenue Market Share by Region (2021-2026)
Table 6. Cadila Healthcare Corporate Information, Head Office, and Major Competitors
Table 7. Cadila Healthcare Major Business
Table 8. Cadila Healthcare Covid-19 Therapeutic Product and Solutions
Table 9. Cadila Healthcare Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Covid-19 Therapeutic Product and Solutions
Table 13. Johnson & Johnson Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ImmunoPrecise Corporate Information, Head Office, and Major Competitors
Table 15. ImmunoPrecise Major Business
Table 16. ImmunoPrecise Covid-19 Therapeutic Product and Solutions
Table 17. ImmunoPrecise Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Novartis Corporate Information, Head Office, and Major Competitors
Table 19. Novartis Major Business
Table 20. Novartis Covid-19 Therapeutic Product and Solutions
Table 21. Novartis Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 23. AstraZeneca Major Business
Table 24. AstraZeneca Covid-19 Therapeutic Product and Solutions
Table 25. AstraZeneca Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Cipla Corporate Information, Head Office, and Major Competitors
Table 27. Cipla Major Business
Table 28. Cipla Covid-19 Therapeutic Product and Solutions
Table 29. Cipla Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. AbbVie Corporate Information, Head Office, and Major Competitors
Table 31. AbbVie Major Business
Table 32. AbbVie Covid-19 Therapeutic Product and Solutions
Table 33. AbbVie Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Bayer Corporate Information, Head Office, and Major Competitors
Table 35. Bayer Major Business
Table 36. Bayer Covid-19 Therapeutic Product and Solutions
Table 37. Bayer Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 39. Regeneron Pharmaceuticals Major Business
Table 40. Regeneron Pharmaceuticals Covid-19 Therapeutic Product and Solutions
Table 41. Regeneron Pharmaceuticals Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Ascletis Pharma Corporate Information, Head Office, and Major Competitors
Table 43. Ascletis Pharma Major Business
Table 44. Ascletis Pharma Covid-19 Therapeutic Product and Solutions
Table 45. Ascletis Pharma Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 47. GlaxoSmithKline Major Business
Table 48. GlaxoSmithKline Covid-19 Therapeutic Product and Solutions
Table 49. GlaxoSmithKline Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Gilead Sciences Corporate Information, Head Office, and Major Competitors
Table 51. Gilead Sciences Major Business
Table 52. Gilead Sciences Covid-19 Therapeutic Product and Solutions
Table 53. Gilead Sciences Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Pharmstandard Corporate Information, Head Office, and Major Competitors
Table 55. Pharmstandard Major Business
Table 56. Pharmstandard Covid-19 Therapeutic Product and Solutions
Table 57. Pharmstandard Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Fujifilm Holdings Corporate Information, Head Office, and Major Competitors
Table 59. Fujifilm Holdings Major Business
Table 60. Fujifilm Holdings Covid-19 Therapeutic Product and Solutions
Table 61. Fujifilm Holdings Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Zhejiang Hisun Pharmaceutical Co. Ltd Corporate Information, Head Office, and Major Competitors
Table 63. Zhejiang Hisun Pharmaceutical Co. Ltd Major Business
Table 64. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Product and Solutions
Table 65. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Roche Corporate Information, Head Office, and Major Competitors
Table 67. Roche Major Business
Table 68. Roche Covid-19 Therapeutic Product and Solutions
Table 69. Roche Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Sanofi Corporate Information, Head Office, and Major Competitors
Table 71. Sanofi Major Business
Table 72. Sanofi Covid-19 Therapeutic Product and Solutions
Table 73. Sanofi Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Pfizer Corporate Information, Head Office, and Major Competitors
Table 75. Pfizer Major Business
Table 76. Pfizer Covid-19 Therapeutic Product and Solutions
Table 77. Pfizer Covid-19 Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Global Covid-19 Therapeutic Revenue (USD Million) by Players (2019-2021)
Table 79. Global Covid-19 Therapeutic Revenue Share by Players (2019-2021)
Table 80. Breakdown of Covid-19 Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 81. Covid-19 Therapeutic Players Head Office, Products and Services Provided
Table 82. Covid-19 Therapeutic Mergers & Acquisitions in the Past Five Years
Table 83. Covid-19 Therapeutic New Entrants and Expansion Plans
Table 84. Global Covid-19 Therapeutic Revenue (USD Million) by Type (2016-2021)
Table 85. Global Covid-19 Therapeutic Revenue Share by Type (2016-2021)
Table 86. Global Covid-19 Therapeutic Revenue Forecast by Type (2021-2026)
Table 87. Global Covid-19 Therapeutic Revenue by Application (2016-2021)
Table 88. Global Covid-19 Therapeutic Revenue Forecast by Application (2021-2026)
Table 89. North America Covid-19 Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 90. North America Covid-19 Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 91. North America Covid-19 Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 92. North America Covid-19 Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 93. North America Covid-19 Therapeutic Revenue by Country (2016-2021) & (USD Million)
Table 94. North America Covid-19 Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 95. Europe Covid-19 Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 96. Europe Covid-19 Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 97. Europe Covid-19 Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 98. Europe Covid-19 Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 99. Europe Covid-19 Therapeutic Revenue by Country (2016-2021) & (USD Million)
Table 100. Europe Covid-19 Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 101. Asia-Pacific Covid-19 Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 102. Asia-Pacific Covid-19 Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific Covid-19 Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 104. Asia-Pacific Covid-19 Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific Covid-19 Therapeutic Revenue by Region (2016-2021) & (USD Million)
Table 106. Asia-Pacific Covid-19 Therapeutic Revenue by Region (2021-2026) & (USD Million)
Table 107. South America Covid-19 Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 108. South America Covid-19 Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 109. South America Covid-19 Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 110. South America Covid-19 Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 111. South America Covid-19 Therapeutic Revenue by Country (2016-2021) & (USD Million)
Table 112. South America Covid-19 Therapeutic Revenue by Country (2021-2026) & (USD Million)
Table 113. Middle East & Africa Covid-19 Therapeutic Revenue by Type (2016-2021) & (USD Million)
Table 114. Middle East & Africa Covid-19 Therapeutic Revenue by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa Covid-19 Therapeutic Revenue by Application (2016-2021) & (USD Million)
Table 116. Middle East & Africa Covid-19 Therapeutic Revenue by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa Covid-19 Therapeutic Revenue by Country (2016-2021) & (USD Million)
Table 118. Middle East & Africa Covid-19 Therapeutic Revenue by Country (2021-2026) & (USD Million)

List Of Figures

LIST OF FIGURES

Figure 1. Covid-19 Therapeutic Picture
Figure 2. Global Covid-19 Therapeutic Revenue Market Share by Type in 2020
Figure 3. Immunotherapy
Figure 4. Life Support
Figure 5. Antiviral Medicine
Figure 6. Plasma Therapy
Figure 7. Others
Figure 8. Covid-19 Therapeutic Revenue Market Share by Application in 2020
Figure 9. Children Picture
Figure 10. Adult Picture
Figure 11. Global Covid-19 Therapeutic Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Covid-19 Therapeutic Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Covid-19 Therapeutic Revenue Market Share by Region (2016-2026)
Figure 14. Global Covid-19 Therapeutic Revenue Market Share by Region in 2020
Figure 15. North America Covid-19 Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Covid-19 Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Covid-19 Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Covid-19 Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Covid-19 Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Covid-19 Therapeutic Market Drivers
Figure 21. Covid-19 Therapeutic Market Restraints
Figure 22. Covid-19 Therapeutic Market Trends
Figure 23. Cadila Healthcare Recent Developments and Future Plans
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. ImmunoPrecise Recent Developments and Future Plans
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. AstraZeneca Recent Developments and Future Plans
Figure 28. Cipla Recent Developments and Future Plans
Figure 29. AbbVie Recent Developments and Future Plans
Figure 30. Bayer Recent Developments and Future Plans
Figure 31. Regeneron Pharmaceuticals Recent Developments and Future Plans
Figure 32. Ascletis Pharma Recent Developments and Future Plans
Figure 33. GlaxoSmithKline Recent Developments and Future Plans
Figure 34. Gilead Sciences Recent Developments and Future Plans
Figure 35. Pharmstandard Recent Developments and Future Plans
Figure 36. Fujifilm Holdings Recent Developments and Future Plans
Figure 37. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Developments and Future Plans
Figure 38. Roche Recent Developments and Future Plans
Figure 39. Sanofi Recent Developments and Future Plans
Figure 40. Pfizer Recent Developments and Future Plans
Figure 41. Global Covid-19 Therapeutic Revenue Share by Players in 2020
Figure 42. Covid-19 Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 43. Global Top 3 Players Covid-19 Therapeutic Revenue Market Share in 2020
Figure 44. Global Top 10 Players Covid-19 Therapeutic Revenue Market Share in 2020
Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 46. Global Covid-19 Therapeutic Revenue Share by Type in 2020
Figure 47. Global Covid-19 Therapeutic Market Share Forecast by Type (2021-2026)
Figure 48. Global Covid-19 Therapeutic Revenue Share by Application in 2020
Figure 49. Global Covid-19 Therapeutic Market Share Forecast by Application (2021-2026)
Figure 50. North America Covid-19 Therapeutic Sales Market Share by Type (2016-2026)
Figure 51. North America Covid-19 Therapeutic Sales Market Share by Application (2016-2026)
Figure 52. North America Covid-19 Therapeutic Revenue Market Share by Country (2016-2026)
Figure 53. United States Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Canada Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Mexico Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Europe Covid-19 Therapeutic Sales Market Share by Type (2016-2026)
Figure 57. Europe Covid-19 Therapeutic Sales Market Share by Application (2016-2026)
Figure 58. Europe Covid-19 Therapeutic Revenue Market Share by Country (2016-2026)
Figure 59. Germany Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. France Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. United Kingdom Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Russia Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Italy Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Asia-Pacific Covid-19 Therapeutic Sales Market Share by Type (2016-2026)
Figure 65. Asia-Pacific Covid-19 Therapeutic Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Covid-19 Therapeutic Revenue Market Share by Region (2016-2026)
Figure 67. China Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Japan Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South Korea Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. India Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Southeast Asia Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Australia Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. South America Covid-19 Therapeutic Sales Market Share by Type (2016-2026)
Figure 74. South America Covid-19 Therapeutic Sales Market Share by Application (2016-2026)
Figure 75. South America Covid-19 Therapeutic Revenue Market Share by Country (2016-2026)
Figure 76. Brazil Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Argentina Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Middle East and Africa Covid-19 Therapeutic Sales Market Share by Type (2016-2026)
Figure 79. Middle East and Africa Covid-19 Therapeutic Sales Market Share by Application (2016-2026)
Figure 80. Middle East and Africa Covid-19 Therapeutic Revenue Market Share by Country (2016-2026)
Figure 81. Turkey Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 82. Saudi Arabia Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. UAE Covid-19 Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Methodology
Figure 85. Research Process and Data Source